articleTop 10% cited

Evaluation of the Medical and Surgical Treatment Of Chronic Rhinosinusitis: A Prospective, Randomised, Controlled Trial

The Laryngoscope · 2004 · Vol. 114(5) · pp. 923–930

Sameh M. Ragab✉(Tanta University Hospital)Valerie J. Lund(Laryngograph (United Kingdom))Glenis Scadding(Royal National Throat Nose and Ear Hospital)

View via DOI Publisher page

Abstract

CRS should be initially targeted with maximal medical therapy (e.g., a 3 month course of a macrolide antibiotic, douche, and topical steroid), with surgical treatment being reserved for cases refractory to medical therapy. The presence of nasal polyps is not a poor prognostic factor for the efficacy of CRS therapy, either surgical or medical.

Sinusitis and nasal conditions Allergic Rhinitis and Sensitization Asthma and respiratory diseasesMedicineChronic rhinosinusitisMedical therapyRandomized controlled trialSurgeryAcoustic rhinometryMedical treatmentProspective cohort studyNasal polypsRefractory (planetary science)

MeSH terms

FluticasoneAdultAndrostadienesAnti-Inflammatory AgentsEndoscopyFemaleFollow-Up StudiesHumansMaleMiddle AgedNitric OxideProspective StudiesQuality of LifeRhinitisSinusitis

Citations

332

FWCI

12.00

field-weighted impact

References

Percentile

99%

vs. same field & year

Citations per year

Cited by

A Double‐Blind, Randomized, Placebo‐Controlled Trial of Macrolide in the Treatment of Chronic Rhinosinusitis